ArticleFrontiers in immunology2022

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d.

Daria Kowalska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.